某院2020—2022年门诊药房非甾体抗炎药的用药分析

摘要/Abstract

摘要： 目的：分析某院门诊药房非甾体抗炎药的使用情况，探讨临床非甾体抗炎药的用药特点及存在的问题，为促进其合理应用与规范管理提供参考。方法：选取2020—2022年某院门诊药房非甾体抗炎药的用药数据，统计分析其用药频度（DDDs）、日均费用（DDC）及排序比（B/A）等，并对其进行数据分析。结果：某院2020—2022年所使用的非甾体抗炎药共有22种，包含了口服剂型、注射剂型，外用剂型。各剂型总体销售金额呈逐年上升趋势。洛索洛芬钠贴剂和氟比洛芬凝胶贴剂的销售金额居第一、二位。阿司匹林肠溶片的DDDs居第一位，B/A远大于1，其他非甾体抗炎药的B/A均与1相近。结论：2020—2022年某院门诊药房的非甾体抗炎药的临床选用情况与指南推荐基本相符，根据不同患者的特点选用不同治疗方案，做到个体化给药，确保临床用药安全有效，为临床合理用药提供参考依据。

关键词: font-size:medium, ">非甾体抗炎药；销售金额；用药频度；日均费用；用药分析

Abstract: Objective： To analyze the use of non-steroidal anti-inflammatory drugs in outpatient pharmacies of Fudan University Zhongshan Hospital Xiamen Hospital (hereinafter referred to as a hospital). Aiming to provide evidence to promote rational application and standardized management of clinical NSAIDs by investigating their characteristics and development trend. Methods： Survey and extract medication data on NSAIDs in a hospital’s outpatient pharmacy from 2020 to 2022， anti-inflammatory drugs from the outpatient pharmacy of a certain hospital， covering the period from 2020 to 2022. Statistical analysis was conducted to determine the medication frequency （DDDs)， average daily cost (DDC)， and ordering ratio (B/A). Results： There are 22 varieties of non-steroidal anti-inflammatory drugs used in a certain hospital in the past three years， including oral dosage forms， injection dosage forms， and external dosage forms. In each dosage form， annual sales increased. The sales volume of loxoprofen sodium patch and flurbiprofen gel patch ranked first and second. The DDDs of aspirin enteric-coated tablets ranked first， with a ordering ratio much greater than 1，and the B/A ratio of other NSAIDs were around 1. Conclusion： The clinical selection of non-steroidal anti-inflammatory drugs in the outpatient pharmacy of a certain hospital from 2020 to 2022 is basically consistent with the guideline recommendations. Different treatment plans are selected according to the characteristics of different patients to achieve individualized dosing to ensure the safety and effectiveness of clinical medication. providing a reference for clinical rational drug use.

Key words: font-size:medium, ">Non-steroidal anti-inflammatory drugs； Sales Amount； Defined daily dose system； Defined daily cost； Medication analysis

中图分类号:

林丽芬1, 陈沭1, 卢燕辉1, 刘岳金1, 潘海山1, 沈赟2. 某院2020—2022年门诊药房非甾体抗炎药的用药分析[J]. 中国药物评价, 2024, 41(4): 327-330.

LIN Li-fen1, CHEN Shu1, LU Yang-hui1, LIU Yue-jin1, PAN Hai-shang1, SHEN Yun2. Medication Analysis of Non-steroidal Anti-inflammatory Drugs in Outpatient Pharmacies of a Hospital from 2020 to 2022[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2024, 41(4): 327-330.

参考文献

[1] 陈新谦，金有豫，汤光. 新编药物学[M]. 2018版. 北京：人民卫生出版社， 2018：179-208.
     [2] Wallace J L， Vong L. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs[J]. Expert Rev Clin Pharmacol， 2018， 11（10）：1031-1043.
     [3] Catarina， Pereira-Leite， Cláudia， et al. Nonsteroidal Anti-Inflammatory Therapy：A Journey Toward Safety[J]. Medicinal Research Reviews， 2017， 37（4）：802-859.
     [4] Derry S， Wiffen P， Moore A， et al. Topical Nonsteroidal Anti-inflammatory Drugs for Acute Musculoskeletal Pain[J]. JAMA， 2016， 315（8）：813-814.
     [5] Clarke J. Topical NSAIDs come out top for knee OA[J]. Nat Rev Rheumatol， 2021， 17（9）：508.
     [6] Schjerning AM， McGettigan P， Gislason G. Cardiovascular effects and safety of （non-aspirin） NSAIDs[J]. Nat Rev Cardiol， 2020， 17（9）：574-584.
     [7] 翁丽玲，陈继涢，施婷婷，等. 2020-2022年某院住院药房第二类精神药品使用分析[J]. 中国医药科学， 2023， 13（16）：126-130.
     [8] 国家药典委员会. 中华人民共和国药典临床用药须知（化学药和生物制品卷）（2015年版）[S]. 北京：中国医药科技出版社， 2017：133-138.
     [9] 陈春枚，林文宏，赵志斌，等. 国家医保谈判抗肿瘤药物使用动态分析[J]. 海峡药学， 2023， 35（4）：62-66.
     [10] 谢丽晓，蔡啸静，吴丽丽，等. 癌痛麻醉药品处方评价和临床应用分析[J]. 现代实用医学， 2017， 29（5）：640-642.
     [11] 赵欣莹，韩蕾，秦爱萍. 南京市浦口区解热镇痛抗炎药用药情况调查分析[J]. 才智， 2022， 9（3）：181-183.
     [12] Sinniah A， Yazid S， Flower RJ. From NSAIDs to Glucocorticoids and Beyond[J]. Cells， 2021， 10（12）：3524.
     [13] Arfè A， Scotti L， Varas-Lorenzo C， et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries：nested case-control study[J]. BMJ， 2016， 354：i4857.
     [14] Bindu S， Mazumder S， Bandyopadhyay U. Non-steroidal anti-inflammatory drugs （NSAIDs） and organ damage： A current perspective[J]. Biochem Pharmacol， 2020， 180：114-147.
     [15] Schjerning AM， McGettigan P， Gislason G. Cardiovascular effects and safety of （non-aspirin） NSAIDs[J]. Nat Rev Cardiol， 2020， 17（9）：574-584.
     [16] Lind KE， Raban MZ， Georgiou A， et al. NSAID use among residents in 68 residential aged care facilities 2014 to 2017：An analysis of duration， concomitant medication use， and high-risk conditions[J]. Pharmacoepidemiol Drug Saf， 2019， 28（11）：1480-1488.